what was the first glp 1 agonist GLP-1R Agonists for Weight Loss Emerging Frontiers in GLP-1 Therapeutics:
Description
Introduction Significant reductions in cardiovascular events, all-cause mortality, and the advancement of kidney disease are demonstrated by important studies such as FLOW
Thirteen state Medicaid programs are covering GLP-1 drugs for the treatment of obesity this year, down from 16 last year.
What is GLP-1
There is no confirmed elevated risk of suicidality, but surveillance remains warranted
CAS Number: 2381089-83-2
Increasingly, reports suggest a possible association between GLP-1 RA use and enhanced fertility outcomes, particularly in women with obesity or polycystic ovary syndrome (PCOS)
